| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 444 | 514 | 398 | 1.138 | 0 | 0 | 382 | 11.910 | 18.277 |
| Total Income - EUR | - | 444 | 514 | 398 | 1.138 | 0 | 0 | 585 | 11.910 | 18.277 |
| Total Expenses - EUR | - | 801 | 676 | 129 | 414 | 31 | 0 | 39 | 2.512 | 14.466 |
| Gross Profit/Loss - EUR | - | -357 | -161 | 269 | 724 | -31 | 0 | 546 | 9.399 | 3.811 |
| Net Profit/Loss - EUR | - | -371 | -177 | 257 | 690 | -31 | 0 | 535 | 7.874 | 3.214 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Myo-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.979 | 1.890 | 1.855 | 1.819 | 1.785 | 1.745 | 1.750 | 3.293 | 2.395 |
| Current Assets | - | 818 | 1.307 | 1.540 | 2.269 | 2.144 | 2.097 | 2.650 | 9.326 | 16.613 |
| Inventories | - | 290 | 285 | 280 | 274 | 269 | 263 | 264 | 263 | 301 |
| Receivables | - | 445 | 952 | 935 | 0 | 0 | 0 | 2 | 852 | 983 |
| Cash | - | 83 | 70 | 326 | 1.994 | 1.875 | 1.834 | 2.384 | 8.211 | 15.328 |
| Shareholders Funds | - | -6.018 | -6.093 | -5.724 | -4.923 | -4.861 | -4.753 | -4.233 | 3.653 | 6.847 |
| Social Capital | - | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | 8.815 | 9.289 | 9.119 | 9.011 | 8.790 | 8.595 | 8.633 | 8.965 | 12.161 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Myo-Med Srl